These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Disappearance of serum insulin in obese-hyperglycemic mice. Coore HG; Westman S Acta Physiol Scand; 1970 Feb; 78(2):274-9. PubMed ID: 5456891 [No Abstract] [Full Text] [Related]
3. Insulinemia in obese patients before and after fasting cures. Kokot F; Kuska J; Gonciarz Z; Kiecon I Arch Immunol Ther Exp (Warsz); 1971; 19(6):869-78. PubMed ID: 5142898 [No Abstract] [Full Text] [Related]
4. Studies on the effect of thyroxine replacement therapy on the increased insulin response to hyperglycemia in the thyroidectomized dog. Renauld A; Sverdlik RC; Andrade LL; Rodríguez RR Horm Metab Res; 1972 Sep; 4(5):373-6. PubMed ID: 4645933 [No Abstract] [Full Text] [Related]
5. Impairment of glucose tolerance in yellow (Avy/A) (BALB/c X VY) F-1 hybrid mice by hyperglycemic peptide(s) from human pituitary glands. Frigeri LG; Wolff GL; Robel G Endocrinology; 1983 Dec; 113(6):2097-105. PubMed ID: 6357766 [TBL] [Abstract][Full Text] [Related]
6. [The effect of restricted food intake on the glucose and lipid metabolism in obese-hyperglycemic mice]. Hata S Nihon Seirigaku Zasshi; 1970; 32(2):71-5. PubMed ID: 4316108 [No Abstract] [Full Text] [Related]
9. Development of the obese-hyperglycaemic syndrome in mice. Westman S Diabetologia; 1968 Jun; 4(3):141-9. PubMed ID: 5738353 [No Abstract] [Full Text] [Related]
10. Pathogenetic aspects of the obese-hyperglycemic syndrome in mice (genotype obob). I. Function of the pancreatic B-cells. Westman S Diabetologia; 1970 Jun; 6(3):279-83. PubMed ID: 4914665 [No Abstract] [Full Text] [Related]
11. [Insulin activity with antibody-suppressible insulin activity and immunologically measurable insulin in the pancreas and serum of genetically obese and hyperglycemic mice]. Stauffacher W; Vecchio DA; Zahnd GR; Renold AE Helv Physiol Pharmacol Acta; 1966; 24(2):C53-4. PubMed ID: 5973827 [No Abstract] [Full Text] [Related]
12. Differences in the development of the obese-hyperglycemic syndrome in obob and NZO mice. Herberg L; Major E; Hennigs U; Grüneklee D; Freytag G; Gries FA Diabetologia; 1970 Jun; 6(3):292-9. PubMed ID: 4914666 [No Abstract] [Full Text] [Related]
13. Hormonal control of intermediary metabolism in obese hyperglycemic mice. II. Levels of plasma free fatty acid and immunoreactive insulin and liver glycogen. Abraham RR; Dade E; Elliott J; Hems DA Diabetes; 1971 Aug; 20(8):535-41. PubMed ID: 5565000 [No Abstract] [Full Text] [Related]
14. Metabolic effects of short-term fasting in obese hyperglycaemic humans and mice. Belfiore F; Iannello S; Rabuazzo AM; Campione R Int J Obes; 1987; 11(6):631-40. PubMed ID: 2831163 [TBL] [Abstract][Full Text] [Related]